Literature DB >> 19056105

DNA variants, plasma levels and variability of interleukin-6 in myocardial infarction survivors: results from the AIRGENE study.

Petter Ljungman1, Tom Bellander, Fredrik Nyberg, Erik Lampa, Bénédicte Jacquemin, Melanie Kolz, Timo Lanki, John Mitropoulos, Martina Müller, Sally Picciotto, Riccardo Pistelli, Regina Rückerl, Wolfgang Koenig, Annette Peters.   

Abstract

INTRODUCTION: Increased levels of interleukin 6 (IL-6), a marker for systemic inflammation, have been associated with cardiovascular morbidity and mortality.
MATERIALS AND METHODS: We investigated the influence of IL6 gene polymorphisms on mean level and variability of plasma IL-6 in a population of myocardial infarction survivors recruited in six European cities as part of the AIRGENE study. DNA from each individual was collected and genotyped for eight functional and tagging single nucleotide polymorphisms (SNPs) in the IL6 gene.
RESULTS: We analyzed 946 subjects with 5520 repeated plasma samples for IL-6 levels. For four IL6 SNPs in high linkage disequilibrium, heterozygous and homozygous minor allele genotypes were associated with an increase in mean plasma IL-6 levels. SNP rs1800795 was associated with a 6.3% increase in IL-6 (95% confidence interval [CI] 1.7-11,2%) For these SNPs, we found that genotypes associated with higher IL-6 levels also tended to be associated to higher between-individual variability of IL-6 levels on the log-scale than other genotypes. Variability over time within individuals varied little by genotype.
CONCLUSIONS: We found four genetic polymorphisms in the IL6 gene associated with mean level and variability of plasma IL-6 between individuals in myocardial infarction survivors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056105     DOI: 10.1016/j.thromres.2008.10.009

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  10 in total

1.  Single-Nucleotide Polymorphisms in Interleukin 6 (IL-6) Gene Are Associated with Suicide Behavior in an Iranian Population.

Authors:  Mohammad Mahdi Eftekharian; Rezvan Noroozi; Mir Davood Omrani; Zohreh Sharifi; Alireza Komaki; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  J Mol Neurosci       Date:  2018-09-30       Impact factor: 3.444

2.  Modification of the interleukin-6 response to air pollution by interleukin-6 and fibrinogen polymorphisms.

Authors:  Petter Ljungman; Tom Bellander; Alexandra Schneider; Susanne Breitner; Francesco Forastiere; Regina Hampel; Thomas Illig; Bénédicte Jacquemin; Klea Katsouyanni; Stephanie von Klot; Wolfgang Koenig; Timo Lanki; Fredrik Nyberg; Juha Pekkanen; Riccardo Pistelli; Christos Pitsavos; Mårten Rosenqvist; Jordi Sunyer; Annette Peters
Journal:  Environ Health Perspect       Date:  2009-04-06       Impact factor: 9.031

3.  Associations between cytokine genes and a symptom cluster of pain, fatigue, sleep disturbance, and depression in patients prior to breast cancer surgery.

Authors:  Sy-Huey Doong; Anand Dhruva; Laura B Dunn; Claudia West; Steven M Paul; Bruce A Cooper; Charles Elboim; Gary Abrams; John D Merriman; Dale J Langford; Heather Leutwyler; Christina Baggott; Kord Kober; Bradley E Aouizerat; Christine Miaskowski
Journal:  Biol Res Nurs       Date:  2014-10-10       Impact factor: 2.522

4.  CD14 and IL6 polymorphisms are associated with a pro-atherogenic profile in young adults with acute myocardial infarction.

Authors:  Lidio Gonçalves Lima-Neto; Rosario Dominguez Crespo Hirata; André Ducati Luchessi; Vivian Nogueira Silbiger; Marco Antonio Stephano; Marcelo Ferraz Sampaio; Dikran Armaganijan; Mario Hiroyuki Hirata
Journal:  J Thromb Thrombolysis       Date:  2013-10       Impact factor: 2.300

5.  Interaction between air pollution exposure and genes in relation to levels of inflammatory markers and risk of myocardial infarction.

Authors:  Sviatlana Panasevich; Karin Leander; Petter Ljungman; Tom Bellander; Ulf de Faire; Göran Pershagen; Fredrik Nyberg
Journal:  BMJ Open       Date:  2013-09-19       Impact factor: 2.692

6.  Modifying effect of a common polymorphism in the interleukin-6 promoter on the relationship between long-term exposure to traffic-related particulate matter and heart rate variability.

Authors:  Martin Adam; Medea Imboden; Eva Boes; Emmanuel Schaffner; Nino Künzli; Harish Chandra Phuleria; Florian Kronenberg; Jean-Michel Gaspoz; David Carballo; Nicole Probst-Hensch
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

7.  Radon Exposure, IL-6 Promoter Variants, and Lung Squamous Cell Carcinoma in Former Uranium Miners.

Authors:  Shuguang Leng; Cynthia L Thomas; Amanda M Snider; Maria A Picchi; Wenshu Chen; Derall G Willis; Teara G Carr; Jacek Krzeminski; Dhimant Desai; Amin Shantu; Yong Lin; Marty R Jacobson; Steven A Belinsky
Journal:  Environ Health Perspect       Date:  2015-09-15       Impact factor: 9.031

8.  Empowering consumers to PREVENT diet-related diseases through OMICS sciences (PREVENTOMICS): protocol for a parallel double-blinded randomised intervention trial to investigate biomarker-based nutrition plans for weight loss.

Authors:  Mona Adnan Aldubayan; Kristina Pigsborg; Sophia M O Gormsen; Francisca Serra; Mariona Palou; Pedro Mena; Mart Wetzels; Alberto Calleja; Antoni Caimari; Josep Del Bas; Biotza Gutierrez; Faidon Magkos; Mads Fiil Hjorth
Journal:  BMJ Open       Date:  2022-03-29       Impact factor: 2.692

9.  Role of the functional Toll-Like receptor-9 promoter polymorphism (-1237T/C) in increased risk of end-stage renal disease: a case-control study.

Authors:  Hsin-Yi Yang; Kuo-Cheng Lu; Herng-Sheng Lee; Shih-Ming Huang; Yuh-Feng Lin; Chia-Chao Wu; Donald M Salter; Sui-Lung Su
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  Investigating the epigenetic profile of the inflammatory gene IL-6 in late-life depression.

Authors:  Joanne Ryan; Lauren Pilkington; Katharina Neuhaus; Karen Ritchie; Marie-Laure Ancelin; Richard Saffery
Journal:  BMC Psychiatry       Date:  2017-10-25       Impact factor: 3.630

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.